lymphoma

Take a break and read all about it

Tell Your Story

Jamie’s Story

Jamie’s Hodgkin’s lymphoma story defines what GRYT is.

Tell Your Story

The Hero of Self

Jessica has survived multiple cancer diagnoses and swam competitively and she still defined what “GRYT is” for herself. She really *is* superwoman.

Tell Your Story

What You Grow

Rachel puts pen to paper to cope with cancer. Here’s her poem, What You Grow.

Gryt Team Member Stories

I woke up with a tube in my neck

Gryt Health team Member, Christian Bullock, shares a very specific lymphoma experience he had. Read his story and let us know about your medical triggers or the medical equipment you’ve dealt with.

Announcements

FDA grants accelerated approval to Tafasitamab-cxix for diffuse large B-cell lymphoma

As of January 2021, the Food and Drug Administration (FDA) has announced the approval of a new medication for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, who are not eligible for autologous stem cell transplant. The new drug, called Monjuvi (tafasitimab) is a targeted therapy that will be used in combination with lenalidomide (Revlimid). Other combinations are currently under investigation.

Tell Your Story

The Cut Into My Dignity

Jessica shares about the hit her dignity took when she received a second cancer diagnosis and learned she would lose a breast at age 25.

Do You Want To Boost Your Business?

drop us a line and keep in touch

GVCC giveaway

Register and attend GVCC to win!

Happening virtually on November 2nd-5th, 2022, our fourth annual conference has sessions geared toward cancer patients, survivors, caregivers, advocates, cancer care professionals, and new this year, those interested in early detection and prevention.